MHRA kicks off new ac­cel­er­at­ed drug ap­proval path­way with ‘in­no­va­tion pass­ports’

As the UK no longer par­tic­i­pates in the Eu­ro­pean Med­i­cines Agency, the coun­try’s drug reg­u­la­tor is get­ting cre­ative in try­ing to at­tract top bio­phar­ma com­pa­nies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.